Association between matrix-metalloproteinase polymorphisms and prostate cancer risk: a meta-analysis and systematic review

References

• CollakFKDemirUOzkanliSKurumEZerkPEIncreased expression of YAP1 in prostate cancer correlates with extraprostatic extensionCancer Biol Med201714440541329372107
   PubMed Web of Science ®Google Scholar
• DaiJShenWWenWEstimation of heritability for nine common cancers using data from genome-wide association studies in Chinese populationInt J Cancer2017140232933627668986
   PubMed Web of Science ®Google Scholar
• GengPLiJWangNPSCA rs2294008 polymorphism with increased risk of cancerPLoS One2015108e013626926308216
   PubMed Web of Science ®Google Scholar
• RadiskyESRaeeszadeh-SarmazdehMRadiskyDCTherapeutic potential of matrix metalloproteinase inhibition in breast cancerJ Cell Biochem2017118113531354828585723
   PubMed Web of Science ®Google Scholar
• EgebladMWerbZNew functions for the matrix metalloproteinases in cancer progressionNat Rev Cancer20022316117411990853
   PubMed Web of Science ®Google Scholar
• AlbayrakSCangüvenOGöktaşCAydemirHKöksalVRole of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish populationUrol Int200779431231518025848
   PubMed Web of Science ®Google Scholar
• JacobsEJHsingAWBainEBPolymorphisms in angiogenesis-related genes and prostate cancerCancer Epidemiol Biomarkers Prev200817497297718398039
   PubMed Web of Science ®Google Scholar
• dos ReisSTPontesJVillanovaFEGenetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancerJ Urol200918152320232519303106
   PubMed Web of Science ®Google Scholar
• TsuchiyaNNaritaSKumazawaTClinical significance of a single nucleotide polymorphism and allelic imbalance of matrix metalloproteinase-1 promoter region in prostate cancerOncol Rep200922349343919639194
   PubMed Web of Science ®Google Scholar
• SrivastavaPLoneTAKapoorRMittalRDAssociation of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North IndiaArch Med Res201243211712422374248
   PubMed Web of Science ®Google Scholar
• SrivastavaPKapoorRMittalRDImpact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohortGene2013530227327723872201
   PubMed Web of Science ®Google Scholar
• YaykaşliKOKayikçiMAYamakNPolymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancerTurk J Med Sci201444583984325539555
   PubMed Web of Science ®Google Scholar
• AdabiZMohsen ZiaeiSAImaniMGenetic polymorphism of MMP2 gene and susceptibility to prostate cancerArch Med Res201546754655026319608
   PubMed Web of Science ®Google Scholar
• SalavatiLSTafviziFManjiliHKThe association between MMP2 -1306 C > T (rs243865) polymorphism and risk of prostate cancerIr J Med Sci2017186110311127541146
   PubMed Web of Science ®Google Scholar
• MoherDLiberatiATetzlaffJAltman DGPRISMA GroupPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementInt J Surg20108533634120171303
   PubMed Web of Science ®Google Scholar
• ThakkinstianAMckayGJMcevoyMSystematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysisAm J Epidemiol2011173121365137921576320
   PubMed Web of Science ®Google Scholar
• WengHZengXTWangXHLiuTZHeDLGenetic Association between Matrix Metalloproteinases Gene Polymorphisms and Risk of Prostate Cancer: A Meta-AnalysisFront Physiol2017897529249982
   PubMed Web of Science ®Google Scholar
• LiuKGuSLiuXThe MMP2 rs243865 polymorphism increases the risk of prostate cancer: A meta-analysisOncotarget2017842729337293829069837
   PubMedGoogle Scholar
• HaqueSAkhterNLohaniMAliAMandalRKMatrix metal-loproteinase-2 -1306 C>T gene polymorphism is associated with reduced risk of cancer: a meta-analysisAsian Pac J Cancer Prev201516388989625735378
   PubMedGoogle Scholar
• LiuMZhaoYYYangFEvidence for a role of GPRC6A in prostate cancer metastasis based on case-control and in vitro analysesEur Rev Med Pharmacol Sci201620112235224827338047
   PubMed Web of Science ®Google Scholar
• BenJJinGZhangYClass A scavenger receptor deficiency exacerbates lung tumorigenesis by cultivating a procarcinogenic microenvironment in humans and miceAm J Respir Crit Care Med2012186876377222878280
   PubMed Web of Science ®Google Scholar
• AmankwahEKSellersTAParkJYGene variants in the angio-genesis pathway and prostate cancerCarcinogenesis20123371259126922523086
   PubMed Web of Science ®Google Scholar
• Nangia-MakkerPWangYRazTCleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancerInt J Cancer2010127112530254120162566
   PubMed Web of Science ®Google Scholar
• AhirwarDKMittalRDRe: Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. S. T. dos Reis, J. Pontes, Jr., F. E. Villanova, P. M. D. Borra, A. A. Antunes, M. F. Dall’oglio, M. Srougi and K. R. M. Leite. J Urol 2009; 181: 2320-2325J Urol201018331258
   PubMed Web of Science ®Google Scholar
• JainSChakrabortyGKunduGCThe crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesisCancer Res200666136638664816818637
   PubMed Web of Science ®Google Scholar
• SchveigertDValuckasKPKovalcisVUlysAChvatovicGDidziap-etrieneJSignificance of MMP-9 expression and MMP-9 polymorphism in prostate cancerTumori201399452352924326842
   PubMed Web of Science ®Google Scholar
• JaboinJJHwangMLopaterZThe matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancerInt J Radiat Oncol Biol Phys20117951330133520605361
   PubMed Web of Science ®Google Scholar
• Gil UgarteburuRRivas del FresnoMGonzález RodríguezIMatrix metalloproteinase- 9 polymorphisms in the diagnosis of prostate cancer. A preliminary experienceArch Esp Urol201063212513220354277
   PubMedGoogle Scholar
• dos ReisSTVillanovaFEAndradePMMatrix metalloprotein-ase-2 polymorphism is associated with prognosis in prostate cancerUrol Oncol201028662462719117773
   PubMed Web of Science ®Google Scholar
• dos ReisSTVillanovaFEde AndradePMPolymorphisms of the matrix metalloproteinases associated with prostate cancerMol Med Rep20081451752021479442
   PubMed Web of Science ®Google Scholar
• Profile StudyAustralian Prostate Cancer BioResource (APCB)IMPACT StudyAssociation analyses of more than 140,000 men identify 63 new prostate cancer susceptibility lociNat Genet201850792893629892016
   PubMed Web of Science ®Google Scholar
• LiaoCHWuHCHuPSThe association of matrix metallopro-teinase-1 Promoter polymorphisms with prostate cancer in taiwanese patientsAnticancer Res20183873907391129970511
   PubMed Web of Science ®Google Scholar
• BiałkowskaKMarciniakWMuszyńskaMAssociation of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish populationPLoS One2018137e020106530036379
   PubMed Web of Science ®Google Scholar
• LeeCJiaZRahmatpanahFRole of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signalingBiomed Res Int20142014502093825089270
   PubMed Web of Science ®Google Scholar
• DayerCStamenkovicIRecruitment of matrix metalloproteinase-9 (MMP-9) to the fibroblast cell surface by lysyl hydroxylase 3 (LH3) triggers transforming growth factor-β (TGF-β) activation and fibroblast differentiationJ Biol Chem201529022137631377825825495
   PubMed Web of Science ®Google Scholar